Copyright Reports & Markets. All rights reserved.

Global Prostaglandin Market Size study, by Type (Human Prostaglandin, Veterinary Prostaglandin), Application (Cardiovascular, Digestive, Gynecological & Obstetrical, Ophthalmologic, Others) and Regional Forecasts 2019-2026

Buy now

TABLE OF CONTENTS

    Chapter 1. Executive Summary

    • 1.1. Market Snapshot
    • 1.2. Key Trends
    • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Million)
      • 1.3.1. Prostaglandin Market, by Type, 2016-2026 (USD Million)
      • 1.3.2. Prostaglandin Market, by Application, 2016-2026 (USD Million)
      • 1.3.3. Prostaglandin Market, by Region, 2016-2026 (USD Million)
    • 1.4. Estimation Methodology
    • 1.5. Research Assumption

    Chapter 2. Global Prostaglandin Market Definition and Scope

    • 2.1. Objective of the Study
    • 2.2. Market Definition & Scope
      • 2.2.1. Industry Evolution
      • 2.2.2. Scope of the Study
    • 2.3. Years Considered for the Study
    • 2.4. Currency Conversion Rates

    Chapter 3. Global Prostaglandin Market Dynamics

    • 3.1. See Saw Analysis
      • 3.1.1. Market Drivers
      • 3.1.2. Market Challenges
      • 3.1.3. Market Opportunities

    Chapter 4. Global Prostaglandin Market Industry Analysis

    • 4.1. Porter’s 5 Force Model
      • 4.1.1. Bargaining Power of Buyers
      • 4.1.2. Bargaining Power of Suppliers
      • 4.1.3. Threat of New Entrants
      • 4.1.4. Threat of Substitutes
      • 4.1.5. Competitive Rivalry
      • 4.1.6. Futuristic Approach to Porter’s 5 Force Model
    • 4.2. PEST Analysis
      • 4.2.1. Political Scenario
      • 4.2.2. Economic Scenario
      • 4.2.3. Social Scenario
      • 4.2.4. Technological Scenario
    • 4.3. Key Buying Criteria (On Demand)
    • 4.4. Regulatory Framework (On Demand)
    • 4.5. Investment Vs Adoption Scenario (On Demand)
    • 4.6. Analyst Recommendation & Conclusion

    Chapter 5. Global Prostaglandin Market, by Type

    • 5.1. Market Snapshot
    • 5.2. Market Performance - Potential Model
    • 5.3. Prostaglandin Market, Sub Segment Analysis
      • 5.3.1. Human Prostaglandin
        • 5.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
        • 5.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
      • 5.3.2. Veterinary Prostaglandin
        • 5.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
        • 5.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

      Chapter 6. Global Prostaglandin Market, by Application

      • 6.1. Market Snapshot
      • 6.2. Market Performance - Potential Model
      • 6.3. Prostaglandin Market, Sub Segment Analysis
        • 6.3.1. Cardiovascular
          • 6.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
          • 6.3.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 6.3.2. Digestive
          • 6.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
          • 6.3.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 6.3.3. Gynecological & Obstetrical
          • 6.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
          • 6.3.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 6.3.4. Ophthalmologic
          • 6.3.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
          • 6.3.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 6.3.5. Others
          • 6.3.5.1. Market estimates & forecasts, 2016-2026 (USD Million)
          • 6.3.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Million)

        Chapter 7. Global Prostaglandin Market, by Regional Analysis

        • 7.1. Prostaglandin Market, Regional Market Snapshot (2016-2026)
        • 7.2. North America Prostaglandin Market Snapshot
          • 7.2.1. U.S.
            • 7.2.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.2.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 7.2.2. Canada
            • 7.2.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.2.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 7.3. Europe Prostaglandin Market Snapshot
          • 7.3.1. U.K.
            • 7.3.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.3.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 7.3.2. Germany
            • 7.3.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.3.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 7.3.3. Rest of Europe
            • 7.3.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.3.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.3.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 7.4. Asia Prostaglandin Market Snapshot
          • 7.4.1. China
            • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.4.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 7.4.2. India
            • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.4.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 7.4.3. Japan
            • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.4.3.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 7.4.4. Rest of Asia Pacific
            • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.4.4.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 7.5. Latin America Prostaglandin Market Snapshot
          • 7.5.1. Brazil
            • 7.5.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.5.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 7.5.2. Mexico
            • 7.5.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.5.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
        • 7.6. Rest of The World
          • 7.6.1. South America
            • 7.6.1.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.6.1.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)
          • 7.6.2. Middle East and Africa
            • 7.6.2.1. Market estimates & forecasts, 2016-2026 (USD Million)
            • 7.6.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Million)
            • 7.6.2.3. Application breakdown estimates & forecasts, 2016-2026 (USD Million)

          Chapter 8. Competitive Intelligence

          • 8.1. Company Market Share (Subject to Data Availability)
          • 8.2. Top Market Strategies
          • 8.3. Company Profiles
            • 8.3.1. CEPIA
              • 8.3.1.1. Overview
              • 8.3.1.2. Financial (Subject to Data Availability)
              • 8.3.1.3. Product Summary
              • 8.3.1.4. Recent Developments
            • 8.3.2. Johnson Matthey
            • 8.3.3. Pfizer
            • 8.3.4. Cayman Chemical
            • 8.3.5. EMD Millipore
            • 8.3.6. Yonsung Fine Chemicals
            • 8.3.7. Everlight Chemical
            • 8.3.8. Piramal Enterprises
            • 8.3.9. Bio-Techne Corporation
            • 8.3.10. Mironova Labs
            • 8.3.11. Chirogate

          Chapter 9. Research Process

          • 9.1. Research Process
            • 9.1.1. Data Mining
            • 9.1.2. Analysis
            • 9.1.3. Market Estimation
            • 9.1.4. Validation
            • 9.1.5. Publishing

    Global Prostaglandin Market is valued approximately USD 461.30 million in 2018 and is anticipated to grow with a healthy growth rate of more than 4.84% over the forecast period 2019-2026. Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax. Increasing incidences of digestive problem and rising prevalence of cardiovascular diseases are the factors that contributing towards growth of global Prostaglandin market. Further, prostaglandins help in increasing concentration of cAMP, calcium ions and activate G proteins inside the cells, all of which are involved in the transfer of energy and inflammatory signaling process which is the factor that regulates their demand across various regions. However, high cost of treatment and several side-effects associated with its over-dose such as migraines and decrease the ability to fight with cancer are the factors that anticipated to restrain the market growth during the forecast period. The regional analysis of global Prostaglandin market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.

    Major market player included in this report are:
    CEPIA
    Johnson Matthey
    Pfizer
    Cayman Chemical
    EMD Millipore
    Yonsung Fine Chemicals
    Everlight Chemical
    Piramal Enterprises
    Bio-Techne Corporation
    Mironova Labs
    Chirogate

    The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

    By Type:

    Human Prostaglandin
    Veterinary Prostaglandin

    By Application:

    Cardiovascular
    Digestive
    Gynecological & Obstetrical
    Ophthalmologic
    Others

    By Regions:
    North America
    U.S.
    Canada
    Europe
    UK
    Germany
    Asia Pacific
    China
    India
    Japan
    Latin America
    Brazil
    Mexico
    Rest of the World

    Furthermore, years considered for the study are as follows:

    Historical year – 2016, 2017
    Base year – 2018
    Forecast period – 2019 to 2026

    Target Audience of the Global Prostaglandin Market in Market Study:

    Key Consulting Companies & Advisors
    Large, medium-sized, and small enterprises
    Venture capitalists
    Value-Added Resellers (VARs)
    Third-party knowledge providers
    Investment bankers
    Investors

    Buy now